A regression model combining clinical and molecular markers accurately distinguishes individuals who discontinued luma/iva treatment in our patient cohort.

Predictors associated with chronic-use (prevalent or incident) vs. discontinuing-use or non-use of strong opioids in multivariable logistic regression model (reduced models adjusted for the covariates retained by backward selection).

GYeon Oh (6199697)
Erin L. Abner (848340)
David W. Fardo (326800)
Patricia R. Freeman (6199700)
Daniela C. Moga (6199703)

January 2019

Predictors associated with chronic-use (prevalent or incident) vs. discontinuing-use or non-use of s...

Multivariate regression models of prescription of conventional treatments and recommendation for complementary medicine treatments.

Pierre-Yves Rodondi (3904402)
Julie Dubois (3904405)
Anne-Sylvie Bill (5798063)
Daria Koutaïssoff (5798066)
Jenny Ros (5798069)
Eléonore Aveni (5798072)
Jérôme Pasquier (4268011)
Lilli Herzig (509433)
Isabelle Decosterd (78723)
Bernard Burnand (509435)

September 2018

Multivariate regression models of prescription of conventional treatments and recommendation for com...

Predicting treatment discontinuation among patients with multiple sclerosis: Application of the transtheoretical model of change

Berger, Bruce A.
Hudmon, Karen Suchanek
Liang, Huigang

January 2004

Objective: To delineate factors associated with discontinued use of the multiple sclerosis (MS) medi...

Logistic regression model for distinguishing individuals who discontinued treatment combining clinical and molecular parameters.

Kerstin Pohl (148204)
David P. Nichols (196771)
Jennifer L. Taylor-Cousar (267640)
Milene T. Saavedra (344954)
Matthew J. Strand (139566)
Jerry A. Nick (344955)
Preston E. Bratcher (313359)

December 2018

Logistic regression model for distinguishing individuals who discontinued treatment combining clinic...

Logistic regression model for distinguishing individuals who discontinued treatment due to pulmonary adverse effects employing clinical parameters.

Kerstin Pohl (148204)
David P. Nichols (196771)
Jennifer L. Taylor-Cousar (267640)
Milene T. Saavedra (344954)
Matthew J. Strand (139566)
Jerry A. Nick (344955)
Preston E. Bratcher (313359)

December 2018

Logistic regression model for distinguishing individuals who discontinued treatment due to pulmonary...

Results from a regression model of drug treatment and knowledge of HCV status on sterile syringe use.

Kiva Ariani Fisher (5150489)
Laura Michele Cahill (5150486)
Stephanie Broyles (270894)
Marion Rorke (5150492)
William Thomas Robinson (5150495)

April 2018

Results from a regression model of drug treatment and knowledge of HCV status on sterile syringe ...

Linear regression results between dose and MR biomarkers for all voxels and all patients.

Jeff D. Winter (6009617)
Fabio Y. Moraes (6009620)
Caroline Chung (5249138)
Catherine Coolens (6009623)

November 2018

Linear regression results between dose and MR biomarkers for all voxels and all patients.</p

Linear regression models on the relationship between grip strength, SPPB, and LDH in all participants with hematological cancers.

Efthymios Papadopoulos (13919593)
Daniel Santa Mina (33304)
Ali Abu Helal (13919596)
Shabbir M. H. Alibhai (9545898)

October 2022

Linear regression models on the relationship between grip strength, SPPB, and LDH in all participant...

Linear regression models testing how DNA quantity and purity varied by class and time since death.

Manuel Alejandro Coba-Males (17598547)
Pablo Medrano-Vizcaíno (17598550)
Sandra Enríquez (16469765)
David Brito-Zapata (17598553)
Sarah Martin-Solano (13833648)
Sofía Ocaña-Mayorga (235322)
Gabriel Alberto Carrillo-Bilbao (17598556)
Wilmer Narváez (17598559)
Jaime Antonio Salas (17598562)
Jazzmín Arrivillaga-Henríquez (17598565)
Manuela González-Suárez (227359)
Ana Poveda (1889686)

December 2023

Linear regression models testing how DNA quantity and purity varied by class and time since death.</...

Alternative regression models testing how DNA quantity and purity varied by class and time since death.

Manuel Alejandro Coba-Males (17598547)
Pablo Medrano-Vizcaíno (17598550)
Sandra Enríquez (16469765)
David Brito-Zapata (17598553)
Sarah Martin-Solano (13833648)
Sofía Ocaña-Mayorga (235322)
Gabriel Alberto Carrillo-Bilbao (17598556)
Wilmer Narváez (17598559)
Jaime Antonio Salas (17598562)
Jazzmín Arrivillaga-Henríquez (17598565)
Manuela González-Suárez (227359)
Ana Poveda (1889686)

December 2023

Alternative regression models testing how DNA quantity and purity varied by class and time since dea...

Linear regression models testing how DNA quantity and purity varied by tissue.

Manuel Alejandro Coba-Males (17598547)
Pablo Medrano-Vizcaíno (17598550)
Sandra Enríquez (16469765)
David Brito-Zapata (17598553)
Sarah Martin-Solano (13833648)
Sofía Ocaña-Mayorga (235322)
Gabriel Alberto Carrillo-Bilbao (17598556)
Wilmer Narváez (17598559)
Jaime Antonio Salas (17598562)
Jazzmín Arrivillaga-Henríquez (17598565)
Manuela González-Suárez (227359)
Ana Poveda (1889686)

December 2023

Linear regression models testing how DNA quantity and purity varied by tissue.</p

Estimated regression coefficients from linear models of whole blood (independent) vs. plasma miRNAs (dependent variable in regression).

Ravi Shah (2635702)
Kahraman Tanriverdi (100180)
Daniel Levy (51573)
Martin Larson (28827)
Mark Gerstein (774)
Eric Mick (515686)
Joel Rozowsky (48216)
Robert Kitchen (2635699)
Venkatesh Murthy (2635693)
Ekaterina Mikalev (2635696)
Jane E. Freedman (100167)

April 2016

Each model was adjusted for age, sex, and RNA characteristics as specified in text. A P-value thr...

Summaries of logistic regression models for different combinations of miRNAs in validation cohort accounting for age, PSA, stage and biopsy characteristics.

Siao-Yi Wang (571821)
Stephen Shiboski (232537)
Cassandra D. Belair (571822)
Matthew R. Cooperberg (571823)
Jeffrey P. Simko (571824)
Hubert Stoppler (571825)
Janet Cowan (571826)
Peter R. Carroll (207144)
Robert Blelloch (161328)

June 2014

Summaries of logistic regression models for different combinations of miRNAs in validation cohort...

Logistic (OR [95%CI]) regression models predicting a CCI≥1 in the whole cohort of patients (No. = 939).

Davide Oreggia (5620763)
Eugenio Ventimiglia (3366782)
Paolo Capogrosso (3366773)
Luca Boeri (3366776)
Walter Cazzaniga (5620766)
Filippo Pederzoli (5620769)
Francesco Chierigo (5620772)
Federico Dehò (5620775)
Francesco Montorsi (296618)
Andrea Salonia (3366761)

August 2018

Logistic (OR [95%CI]) regression models predicting a CCI≥1 in the whole cohort of patients (No. = 93...

Regression analysis using the proportional hazard model for the time to failure of VCM therapy.

Atsushi Komoto (2174140)
Takayoshi Maiguma (5725052)
Daisuke Teshima (5725055)
Tetsuhiro Sugiyama (5725058)
Yuto Haruki (5725061)

September 2018

Regression analysis using the proportional hazard model for the time to failure of VCM therapy.</p

Predictors associated with chronic-use (prevalent or incident) vs. discontinuing-use or non-use of strong opioids in multivariable logistic regression model (reduced models adjusted for the covariates retained by backward selection).

GYeon Oh (6199697)
Erin L. Abner (848340)
David W. Fardo (326800)
Patricia R. Freeman (6199700)
Daniela C. Moga (6199703)

January 2019

Predictors associated with chronic-use (prevalent or incident) vs. discontinuing-use or non-use of s...

Multivariate regression models of prescription of conventional treatments and recommendation for complementary medicine treatments.

Pierre-Yves Rodondi (3904402)
Julie Dubois (3904405)
Anne-Sylvie Bill (5798063)
Daria Koutaïssoff (5798066)
Jenny Ros (5798069)
Eléonore Aveni (5798072)
Jérôme Pasquier (4268011)
Lilli Herzig (509433)
Isabelle Decosterd (78723)
Bernard Burnand (509435)

September 2018

Multivariate regression models of prescription of conventional treatments and recommendation for com...

Predicting treatment discontinuation among patients with multiple sclerosis: Application of the transtheoretical model of change

Berger, Bruce A.
Hudmon, Karen Suchanek
Liang, Huigang

January 2004

Objective: To delineate factors associated with discontinued use of the multiple sclerosis (MS) medi...

Logistic regression model for distinguishing individuals who discontinued treatment combining clinical and molecular parameters.

Kerstin Pohl (148204)
David P. Nichols (196771)
Jennifer L. Taylor-Cousar (267640)
Milene T. Saavedra (344954)
Matthew J. Strand (139566)
Jerry A. Nick (344955)
Preston E. Bratcher (313359)

December 2018

Logistic regression model for distinguishing individuals who discontinued treatment combining clinic...

Logistic regression model for distinguishing individuals who discontinued treatment due to pulmonary adverse effects employing clinical parameters.

Kerstin Pohl (148204)
David P. Nichols (196771)
Jennifer L. Taylor-Cousar (267640)
Milene T. Saavedra (344954)
Matthew J. Strand (139566)
Jerry A. Nick (344955)
Preston E. Bratcher (313359)

December 2018

Logistic regression model for distinguishing individuals who discontinued treatment due to pulmonary...

Results from a regression model of drug treatment and knowledge of HCV status on sterile syringe use.

Kiva Ariani Fisher (5150489)
Laura Michele Cahill (5150486)
Stephanie Broyles (270894)
Marion Rorke (5150492)
William Thomas Robinson (5150495)

April 2018

Results from a regression model of drug treatment and knowledge of HCV status on sterile syringe ...

Linear regression results between dose and MR biomarkers for all voxels and all patients.

Jeff D. Winter (6009617)
Fabio Y. Moraes (6009620)
Caroline Chung (5249138)
Catherine Coolens (6009623)

November 2018

Linear regression results between dose and MR biomarkers for all voxels and all patients.</p

Linear regression models on the relationship between grip strength, SPPB, and LDH in all participants with hematological cancers.

Efthymios Papadopoulos (13919593)
Daniel Santa Mina (33304)
Ali Abu Helal (13919596)
Shabbir M. H. Alibhai (9545898)

October 2022

Linear regression models on the relationship between grip strength, SPPB, and LDH in all participant...

Linear regression models testing how DNA quantity and purity varied by class and time since death.

Manuel Alejandro Coba-Males (17598547)
Pablo Medrano-Vizcaíno (17598550)
Sandra Enríquez (16469765)
David Brito-Zapata (17598553)
Sarah Martin-Solano (13833648)
Sofía Ocaña-Mayorga (235322)
Gabriel Alberto Carrillo-Bilbao (17598556)
Wilmer Narváez (17598559)
Jaime Antonio Salas (17598562)
Jazzmín Arrivillaga-Henríquez (17598565)
Manuela González-Suárez (227359)
Ana Poveda (1889686)

December 2023

Linear regression models testing how DNA quantity and purity varied by class and time since death.</...

Alternative regression models testing how DNA quantity and purity varied by class and time since death.

Manuel Alejandro Coba-Males (17598547)
Pablo Medrano-Vizcaíno (17598550)
Sandra Enríquez (16469765)
David Brito-Zapata (17598553)
Sarah Martin-Solano (13833648)
Sofía Ocaña-Mayorga (235322)
Gabriel Alberto Carrillo-Bilbao (17598556)
Wilmer Narváez (17598559)
Jaime Antonio Salas (17598562)
Jazzmín Arrivillaga-Henríquez (17598565)
Manuela González-Suárez (227359)
Ana Poveda (1889686)

December 2023

Alternative regression models testing how DNA quantity and purity varied by class and time since dea...

Linear regression models testing how DNA quantity and purity varied by tissue.

Manuel Alejandro Coba-Males (17598547)
Pablo Medrano-Vizcaíno (17598550)
Sandra Enríquez (16469765)
David Brito-Zapata (17598553)
Sarah Martin-Solano (13833648)
Sofía Ocaña-Mayorga (235322)
Gabriel Alberto Carrillo-Bilbao (17598556)
Wilmer Narváez (17598559)
Jaime Antonio Salas (17598562)
Jazzmín Arrivillaga-Henríquez (17598565)
Manuela González-Suárez (227359)
Ana Poveda (1889686)

December 2023

Linear regression models testing how DNA quantity and purity varied by tissue.</p

Estimated regression coefficients from linear models of whole blood (independent) vs. plasma miRNAs (dependent variable in regression).

Ravi Shah (2635702)
Kahraman Tanriverdi (100180)
Daniel Levy (51573)
Martin Larson (28827)
Mark Gerstein (774)
Eric Mick (515686)
Joel Rozowsky (48216)
Robert Kitchen (2635699)
Venkatesh Murthy (2635693)
Ekaterina Mikalev (2635696)
Jane E. Freedman (100167)

April 2016

Each model was adjusted for age, sex, and RNA characteristics as specified in text. A P-value thr...

Summaries of logistic regression models for different combinations of miRNAs in validation cohort accounting for age, PSA, stage and biopsy characteristics.

Siao-Yi Wang (571821)
Stephen Shiboski (232537)
Cassandra D. Belair (571822)
Matthew R. Cooperberg (571823)
Jeffrey P. Simko (571824)
Hubert Stoppler (571825)
Janet Cowan (571826)
Peter R. Carroll (207144)
Robert Blelloch (161328)

June 2014

Summaries of logistic regression models for different combinations of miRNAs in validation cohort...

Logistic (OR [95%CI]) regression models predicting a CCI≥1 in the whole cohort of patients (No. = 939).

Davide Oreggia (5620763)
Eugenio Ventimiglia (3366782)
Paolo Capogrosso (3366773)
Luca Boeri (3366776)
Walter Cazzaniga (5620766)
Filippo Pederzoli (5620769)
Francesco Chierigo (5620772)
Federico Dehò (5620775)
Francesco Montorsi (296618)
Andrea Salonia (3366761)

August 2018

Logistic (OR [95%CI]) regression models predicting a CCI≥1 in the whole cohort of patients (No. = 93...

Regression analysis using the proportional hazard model for the time to failure of VCM therapy.

Atsushi Komoto (2174140)
Takayoshi Maiguma (5725052)
Daisuke Teshima (5725055)
Tetsuhiro Sugiyama (5725058)
Yuto Haruki (5725061)

September 2018

Regression analysis using the proportional hazard model for the time to failure of VCM therapy.</p

Predictors associated with chronic-use (prevalent or incident) vs. discontinuing-use or non-use of strong opioids in multivariable logistic regression model (reduced models adjusted for the covariates retained by backward selection).

GYeon Oh (6199697)
Erin L. Abner (848340)
David W. Fardo (326800)
Patricia R. Freeman (6199700)
Daniela C. Moga (6199703)

January 2019

Predictors associated with chronic-use (prevalent or incident) vs. discontinuing-use or non-use of s...

Multivariate regression models of prescription of conventional treatments and recommendation for complementary medicine treatments.

Pierre-Yves Rodondi (3904402)
Julie Dubois (3904405)
Anne-Sylvie Bill (5798063)
Daria Koutaïssoff (5798066)
Jenny Ros (5798069)
Eléonore Aveni (5798072)
Jérôme Pasquier (4268011)
Lilli Herzig (509433)
Isabelle Decosterd (78723)
Bernard Burnand (509435)

September 2018

Multivariate regression models of prescription of conventional treatments and recommendation for com...

Predicting treatment discontinuation among patients with multiple sclerosis: Application of the transtheoretical model of change

Berger, Bruce A.
Hudmon, Karen Suchanek
Liang, Huigang

January 2004

Objective: To delineate factors associated with discontinued use of the multiple sclerosis (MS) medi...

A regression model combining clinical and molecular markers accurately distinguishes individuals who discontinued luma/iva treatment in our patient cohort.

Abstract

Extracted data

A regression model combining clinical and molecular markers accurately distinguishes individuals who discontinued luma/iva treatment in our patient cohort.

Abstract

Extracted data

Related items

Related items